The old dog glanced at $MRNA ’s on-chain US stock perpetual futures: in the last 24 hours it’s up 9.295%, with the price holding at 183.67. The funding rate hasn’t moved at all—it’s pinned at zero. The open interest is 12,416.04 contracts. It’s soaring, but not a penny has been exchanged between longs and shorts. That’s a bit unusual.
By the “funding rate law,” a funding rate greater than zero is the signal that longs are crowded and a pullback should be watched for. Now the rate is zero, and the price is rising—most likely short covering or spot-side funding pushing the move, while the leveraged positions haven’t caught up yet. The number 12,416.04 isn’t meaningful by itself without a benchmark, but based on the trading volume of $12,026,815.9589, turnover isn’t low. Yet with the funding rate staying unchanged, it suggests new long positions aren’t very eager to open. The old dog judges that this rally is a rebound driven by short covering, not the start of a trend-wide breakout.
The strongest counter-evidence: if over the next few hours the funding rate turns positive and open interest rapidly increases, then my view won’t hold, because that would mean fresh leveraged longs are stepping in as the next leg of the rally. But the current data supports only one signal: price up while funding stays flat. The market is standing by. The second-order effects are straightforward too: once shorts have closed out, if there’s no new buying, the price is likely to fall back. Those who chased higher would bear the pullback cost, and liquidity could rotate to other instruments with a funding-rate spread to arb.
Invalidation conditions are clear: there are two triggers that will make me withdraw the judgment. First, the funding rate turns positive by more than 0.001%. Second, open interest drops below 10,000 or rises above 15,000. If either happens, it means the balance of power between longs and shorts has changed. As for action: don’t touch it now—just keep observing. If you want to probe with a small position, you still have to wait for funding rate or open interest to give a clear direction. For example, if the funding rate turns positive while open interest increases, then I’d consider going long; if the funding rate turns negative and open interest declines, then I’d look at it the other way and go short. In short, in the zero-funding phase, the old dog chooses to wait.
Trading tag: #BinanceFutures #TradFi #USDⓈM #MRNA #MRNAUSDT $MRNA
By the “funding rate law,” a funding rate greater than zero is the signal that longs are crowded and a pullback should be watched for. Now the rate is zero, and the price is rising—most likely short covering or spot-side funding pushing the move, while the leveraged positions haven’t caught up yet. The number 12,416.04 isn’t meaningful by itself without a benchmark, but based on the trading volume of $12,026,815.9589, turnover isn’t low. Yet with the funding rate staying unchanged, it suggests new long positions aren’t very eager to open. The old dog judges that this rally is a rebound driven by short covering, not the start of a trend-wide breakout.
The strongest counter-evidence: if over the next few hours the funding rate turns positive and open interest rapidly increases, then my view won’t hold, because that would mean fresh leveraged longs are stepping in as the next leg of the rally. But the current data supports only one signal: price up while funding stays flat. The market is standing by. The second-order effects are straightforward too: once shorts have closed out, if there’s no new buying, the price is likely to fall back. Those who chased higher would bear the pullback cost, and liquidity could rotate to other instruments with a funding-rate spread to arb.
Invalidation conditions are clear: there are two triggers that will make me withdraw the judgment. First, the funding rate turns positive by more than 0.001%. Second, open interest drops below 10,000 or rises above 15,000. If either happens, it means the balance of power between longs and shorts has changed. As for action: don’t touch it now—just keep observing. If you want to probe with a small position, you still have to wait for funding rate or open interest to give a clear direction. For example, if the funding rate turns positive while open interest increases, then I’d consider going long; if the funding rate turns negative and open interest declines, then I’d look at it the other way and go short. In short, in the zero-funding phase, the old dog chooses to wait.
Trading tag: #BinanceFutures #TradFi #USDⓈM #MRNA #MRNAUSDT $MRNA